Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
Oxidative stress, inflammation, and hypertension constitute a self-perpetuating vicious circle to exacerbate hypertension and subsequent hypertensive cardiac hypertrophy. NADPH oxidase (Nox) 1/4 inhibitor GKT137831 alleviates hypertensive cardiac hypertrophy in models of secondary hypertension; howe...
Saved in:
| Main Authors: | Si-yu Zeng, Qiu-jiang Yan, Li Yang, Qing-hua Mei, Hui-qin Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2020/1078365 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FERMT1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by activating EGFR/AKT/β-catenin and EGFR/ERK pathways
by: Wubin Guo, et al.
Published: (2024-12-01) -
ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
by: Mei Xiang, et al.
Published: (2018-09-01) -
Nuclear receptor corepressor 1 represses cardiac hypertrophy
by: Chao Li, et al.
Published: (2019-09-01) -
Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway.
by: Chen Li, et al.
Published: (2016-01-01) -
The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
by: Mikuto Tojima, et al.
Published: (2021-12-01)